Comparative Pharmacology
Head-to-head clinical analysis: NIZORAL ANTI DANDRUFF versus PENLAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NIZORAL ANTI DANDRUFF versus PENLAC.
NIZORAL ANTI-DANDRUFF vs PENLAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ketoconazole, an imidazole antifungal agent, inhibits fungal cytochrome P450 14α-demethylase (CYP51), preventing the conversion of lanosterol to ergosterol, an essential component of fungal cell membranes. This disrupts membrane integrity and function.
Ciclopirox, a hydroxypyridone antifungal, inhibits the uptake of essential elements and disrupts fungal cell membrane integrity by chelating polyvalent cations (Fe3+, Al3+). It also inhibits fungal enzymes involved in energy production and detoxification processes.
Apply to wet hair, lather, and leave on for 3-5 minutes before rinsing. Use twice weekly for 4 weeks, then as needed to control dandruff.
Apply a thin layer to affected nails once daily, preferably at bedtime or 8 hours before washing. Use the provided applicator to apply to the entire nail plate and under the nail tip. Treatment duration is up to 48 weeks.
None Documented
None Documented
Terminal elimination half-life is biphasic: initial 2 hours, terminal 8 hours (range 6-10 hours). After topical application, systemic absorption is minimal, resulting in an effective half-life of 72-96 hours in skin.
Terminal elimination half-life is 17–21 hours in patients with normal renal function; prolonged in renal impairment (up to 40-50 hours in severe renal failure)
Primarily fecal (57%) via biliary excretion as unchanged drug and metabolites; renal excretion accounts for approximately 13% (2-4% unchanged).
Primarily excreted renally as unchanged drug; approximately 90% of absorbed dose recovered in urine within 24 hours; minimal biliary/fecal elimination (<5%)
Category C
Category C
Topical Antifungal
Topical Antifungal